期刊文献+

沙美特罗替卡松吸入治疗儿童哮喘的疗效观察及护理 被引量:1

Effect observation of children with asthma treated with salmeterol fluticasone propionate inhalation and their nursing
下载PDF
导出
摘要 目的:观察沙美特罗替卡松吸入治疗儿童哮喘的疗效和护理方法。方法:按病情轻、中、重度持续不同,分别给予不同剂量沙美特罗替卡松吸入,同时按需使用短效β2受体激动剂吸入,对<7岁的患儿可加用储雾罐。并由专科护士讲解使用方法。结果:治疗2周后,日间、夜间症状、肺部哮鸣音评分显著下降,治疗至6个月时无症状的病例已达99.15%,治疗2周后用万托林的量明显减少。6月时有记录的357例随访中显效355例(99.4%),有效1例(0.3%),无效1例(0.3%),总有效率99.7%。结论:沙美特罗替卡松治疗哮喘,只要用量恰当,吸入的方法正确,可以减少哮喘发作的次数和减轻哮喘发作的程度。 Objective: To observe the methods of nursing and the effect of salmeterol fluticasone propionate (Seretide TM) on children with asthma. Method: Salmeterol fluticasone propionate inhalation of different dosages was given according to different illness condition of asthma. At the same time short-acting β2 agonist (with spacer in children below 7 years old) was used if necessary. Result: There were significant decreases of daytime and noctural symptom, pulmonary wheezing scores and dosage of short-acting β2 agonist at 2 weeks of treatment and there was 99.15% of chidren without symptom at 6 month of treatment. There was 355 cases (99.4%) with significant effect, 1 cases with moderate effect (0.3%) and only one case with no effect (0.3%) and the total effect was 99.7%. Conclusion: The onset time and level of asthma can be decreased with proper dosage and inhalation method of Salmeterol fluticasone propionate.
出处 《儿科药学杂志》 CAS 2005年第2期54-55,共2页 Journal of Pediatric Pharmacy
关键词 沙美特罗替卡松 哮喘 护理 Salmeterol fluticasone propionate Asthma Nursing
  • 相关文献

参考文献4

  • 1全国儿童哮喘协作组.儿童哮喘防治常规[J].中华儿科杂志,1983,36(12):745-745.
  • 2Eickellergo, Roth M, Lox, et al. Ligand-independent activation of the glucocorticoid receptor by b2-adrenergic receptor antagontits in primary hecman lung fibroblasts and vascular smooth muscle cells [J]. Jbiol mol chem, 1999, 274(2): 1005.
  • 3Chung KF. The complementary role glacocorticocorticosteroids and long-acting beta2-adrenerrigicie agonoists[J]. Allergy, 1998,52(42supple): 7.
  • 4Dorinsky, Paul M, Md Yancey, et al. The effectiveness of Fluticasone propionate/salmeterol 100/50MCG DiskusR(FSC) as an inlaled corticosteroid-sparing agent:effect of baseline asthme severity [J]. Chest, 2003, 124(4): s87.

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部